| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5617740 | Journal of Vascular Surgery | 2017 | 8 Pages |
Abstract
Pretreatment with O-3FA reduces the slow-flow phenomenon generated by plaque vulnerability during CAS, and on-going daily use of O-3FA suppresses ISR after CAS.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ichiro MD, PhD, Hun Soo MD, Shohei MD, Takeshi MD, PhD, Syuichi MD, PhD, Yasushi MD, PhD, Kimihiko MD, PhD, Hiroyuki MD, PhD,